Ken Griffin's position in Sage Therapeutics is currently worth $797 Thousand. That's 0.00% of their equity portfolio (3029th largest holding). The first Sage Therapeutics trade was made in Q3 2014. Since then Ken Griffin bought shares 62 more times and sold shares on 44 occasions. The investor's estimated purchase price is $10.4 Million, resulting in a loss of 92%.